Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?
Clinical trial NCT06229184 · COMPLETED
Trial details
- NCT number
- NCT06229184
- Sponsor
- Sisli Hamidiye Etfal Training and Research Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-16
- Primary completion
- 2023-08-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.